Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 12, 2002 - Issue 11
Submit an article Journal homepage
169
Views
105
CrossRef citations to date
0
Altmetric
Review

Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer

Qun Li Abbott Laboratories, Cancer Research, R47S, AP-10, 100 Abbott Park Road, Abbott Park,, IL 60064-6101, USA
&
Hing L Sham Abbott Laboratories, Cancer Research, R47S, AP-10, 100 Abbott Park Road, Abbott Park,, IL 60064-6101, USA
Pages 1663-1702 | Published online: 25 Feb 2005
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Antimitotic agents have generated considerable interest among cytotoxic agents due to the tremendous success of the taxanes and the widespread use of the Vinca alkaloids in clinical oncology. Renewed interest in tubulin polymerisation inhibitors has been generated by the hope that non-multi-drug resistance (MDR) substrates that interact with tubulin at sites near to, overlapping with or different from those of the taxanes or Vinca alkaloids can be discovered. In this article, new antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer are reviewed, with greater emphasis being focused on the small molecule colchicine site binders. Compounds that induce metaphase arrest, by other novel mechanisms, are summarised. Results of clinical trials of drug candidates that fall into these classes are also briefly discussed. The patent literature was surveyed from January 1998 through May 2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target.
Source: Wiley
Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
Source: Taylor & Francis Group
Indole, a core nucleus for potent inhibitors of tubulin polymerization.
Source: Wiley
Nature: a vital source of leads for anticancer drug development
Source: Springer Science and Business Media LLC

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.